BioCytics

BioCytics offers Circulating Tumor Cell isolation, enumeration and analysis services for oncology drug development and research.

BioCytics, Inc. achieves CAP Accreditation

10/26/2011

HUNTERSVILLE, NC—BioCytics, Inc., is pleased to announce it has been awarded accreditation by the College of American Pathologists (CAP) for its Circulating Tumor Cell (CTC) Enumeration assay.  CTCs are cancer cells that travel through the body via the bloodstream.  They are though... read more

BioCytics to attend World CTC Summit in San Diego

10/03/2011

BioCytics will attend the World Circulating Tumor Cell Summit held in San Diego on November 9-10.  This event brings together top CTC researchers from around the world to discuss how to apply current knowledge about CTCs in both a clinical setting and for drug development purposes.  In a... read more